Business
Kushner’s Affinity Partners exits Paramount bid for Warner Bros. Discovery
Jared Kushner, Founder & CEO, Affinity Partners, speaks during the second day of the FII PRIORITY Summit held at the Faena Hotel on Feb. 20, 2025 in Miami Beach, Florida. Joe Raedle | Getty Images Jared Kushner’s firm Affinity Partners has dropped out of Paramount Skydance‘s hostile takeover bid for Warner Bros. Discovery. “With two strong competitors vying […]
Read More
AI future: Big Tech faces key House vote on reforming permit process
Big Tech heavy hitters such as OpenAI, Meta, and Microsoft are pushing for Congress to advance legislation to reform the process for obtaining federal permits for projects to build out artificial intelligence infrastructure in the United States. Backers of the bill, the SPEED Act, argue it is key to helping the U.S. beat out China […]
Read More
Investors are all in on stocks: Bank of America survey shows record low cash level
While the market may be stalling into year-end, investors are keeping the faith, Bank of America data shows. The share of portfolios in cash fell to a record low 3.3% in December, according to the bank’s Global Fund Manager survey. That’s down from 3.7%. Michael Hartnett, chief investment strategist at Bank of America, dubbed the […]
Read More
What Trump’s reclassification of pot and CBD could mean for seniors, research and stocks
Tarek Adieh, of Tampa, Florida, looks at cannabis flower from wholesaler Dep Kings at CHAMPS Trade Show at the Palmer Events Center Thursday, Sept. 11, 2025. Jay Jannar | Hearst Newspapers | Getty Images President Donald Trump is expected to sign an executive order this week that would broadly expand access to cannabis. Industry advocates, […]
Read More
Birkin bag prices are sinking at auction despite high-profile sales
Close-up detail view of a gray Hermes Birkin bag in grained leather, during a street style fashion photo session, on October 28, 2025 in Paris, France. Edward Berthelot | Getty Images Entertainment | Getty Images Despite two recent blockbuster auctions for Birkin bags, overall auction prices for the iconic Hermès handbags are falling, according to […]
Read More
Pfizer’s modest 2026 outlook shows its big investments will take time to pay off
Smith Collection | Archive Photos | Getty Images Pfizer on Tuesday forecast modest 2026 guidance as it looks to longer-term investments in its pipeline to counter waning Covid product sales and declines from older drugs. Those hurdles aren’t surprising or new for Pfizer, which has seen a dramatic decline in Covid vaccine and antiviral sales […]
Read More
Jobs data, Tesla’s rally, tariff revenue hits $200 billion and more in Morning Squawk in Morning Squawk
An employee hiring sign is seen in a window of a business in Arlington, Virginia, April 7, 2023. Elizabeth Frantz | Reuters This is CNBC’s Morning Squawk newsletter. Subscribe here to receive future editions in your inbox. Here are five key things investors need to know to start the trading day: 1. Economics 101 Investors and economic […]
Read More
Stocks making the biggest moves premarket: Pfizer, Roku, Kraft Heinz & more
Check out the companies making headlines before the bell: Pfizer — The pharma giant issued disappointing 2026 earnings guidance. Pfizer a profit between $2.80 per share and $3 per share for the coming year. Analysts polled by LSEG expected earnings per share of $3.05 for 2026. The company also reaffirmed its 2025 outlook. Shares hovered […]
Read More
Kraft Heinz taps former Kellanova CEO Steve Cahillane to lead company ahead of breakup
Kraft Heinz announced plans to split into two separately traded companies, reversing its 2015 megamerger, which was orchestrated by billionaire investor Warren Buffett. Justin Sullivan | Getty Images News | Getty Images Kraft Heinz on Tuesday announced that former Kellanova CEO Steve Cahillane will lead the company ahead of its planned split next year. Cahillane […]
Read More
Europe’s best-performing stock is up 1,400% this year. Here’s what’s next
Key Points Abivax shares are up more than 1,400% year to date as investors are optimistic about the prospects of its treatment for ulcerative colitis. “We are certainly excited about the work we are doing, and we’ve been greeted again by the medical community as becoming possibly this next standard of care in ulcerative colitis,” […]
Read More